Showing results (221-230 of 365) with videos related to

Sort By:
Pageof 37
Immunotargets and Therapy|May 6, 2020
Immunotherapy for Medulloblastoma: Current PerspectivesTanvir F Kabir, Charles A Kunos, John L Villano, et al.
Immunotargets and Therapy|February 27, 2023
A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOXJiangpeng Zhu, Guangyao Li, Zhengjun Zhang, et al.
Immunotargets and Therapy|June 26, 2020
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?Ana Lorenzo-Vizcaya, Serena Fasano, David A Isenberg
Immunotargets and Therapy|November 10, 2025
Profiling Shared Cytotoxic Immune Signatures in SLE-Associated Coronary Injury Through Transcriptomics and Machine LearningYongkang Chen, Shuk Ming Tso, Feng Wu, et al.
Immunotargets and Therapy|October 30, 2025
Regulatory Mechanisms of Co-Inhibitory Receptors in Tuberculosis Immunity: Implications for Therapeutic TargetsHuicong Liu, Haoran Li, Shanshan Li, et al.
Immunotargets and Therapy|July 22, 2025
Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?Rubin Jiao, Ekaterina Dadachova
Immunotargets and Therapy|July 16, 2025
Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer TreatmentIlona Hagelstein, Sven Mattern, Kevin Wang, et al.
Immunotargets and Therapy|July 28, 2025
Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular CarcinomaHyewon Park, Sowon Park, Kena Park, et al.
Immunotargets and Therapy|September 17, 2025
T Cells Dysfunction in Multiple MyelomaLinyu Cai, Liping Zuo, Guangqi Wang, et al.
Immunotargets and Therapy|September 18, 2025
Clinical Outcomes and Hepatic Toxicity of Combined Intensity Modulated Radiotherapy and PD-1 Inhibitors in Child-Pugh Class B Advanced Hepatocellular CarcinomaLijun Chen, Min Liu, Shenshen Chen, et al.
Pageof 37